804 related articles for article (PubMed ID: 25937281)
1. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
[TBL] [Abstract][Full Text] [Related]
2. Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology.
Mianné J; Bourguignon C; Nguyen Van C; Fieldès M; Nasri A; Assou S; De Vos J
Cells; 2020 May; 9(5):. PubMed ID: 32466123
[TBL] [Abstract][Full Text] [Related]
3. A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells.
Howden SE; McColl B; Glaser A; Vadolas J; Petrou S; Little MH; Elefanty AG; Stanley EG
Stem Cell Reports; 2016 Sep; 7(3):508-517. PubMed ID: 27499201
[TBL] [Abstract][Full Text] [Related]
4. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
[TBL] [Abstract][Full Text] [Related]
5. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
[TBL] [Abstract][Full Text] [Related]
6. An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells.
Xie Y; Wang D; Lan F; Wei G; Ni T; Chai R; Liu D; Hu S; Li M; Li D; Wang H; Wang Y
Sci Rep; 2017 May; 7(1):2320. PubMed ID: 28539611
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient CRISPR/Cas9-mediated transgene knockin at the H11 locus in pigs.
Ruan J; Li H; Xu K; Wu T; Wei J; Zhou R; Liu Z; Mu Y; Yang S; Ouyang H; Chen-Tsai RY; Li K
Sci Rep; 2015 Sep; 5():14253. PubMed ID: 26381350
[TBL] [Abstract][Full Text] [Related]
8. Precise and efficient scarless genome editing in stem cells using CORRECT.
Kwart D; Paquet D; Teo S; Tessier-Lavigne M
Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
Santos DP; Kiskinis E; Eggan K; Merkle FT
Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
[TBL] [Abstract][Full Text] [Related]
10. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
Horii T; Hatada I
Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
[TBL] [Abstract][Full Text] [Related]
11. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
[TBL] [Abstract][Full Text] [Related]
12. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
Liu GG; Li S; Wei YD; Zhang YX; Ding QR
Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of SNVs and indels in trio genomes of Cas9-mediated multiplex edited sheep.
Wang X; Liu J; Niu Y; Li Y; Zhou S; Li C; Ma B; Kou Q; Petersen B; Sonstegard T; Huang X; Jiang Y; Chen Y
BMC Genomics; 2018 May; 19(1):397. PubMed ID: 29801435
[TBL] [Abstract][Full Text] [Related]
14. Unexpected genomic rearrangements at targeted loci associated with CRISPR/Cas9-mediated knock-in.
Rezza A; Jacquet C; Le Pillouer A; Lafarguette F; Ruptier C; Billandon M; Isnard Petit P; Trouttet S; Thiam K; Fraichard A; Chérifi Y
Sci Rep; 2019 Mar; 9(1):3486. PubMed ID: 30837594
[TBL] [Abstract][Full Text] [Related]
15. Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells.
Cardenas-Diaz FL; Maguire JA; Gadue P; French DL
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31609348
[TBL] [Abstract][Full Text] [Related]
16. Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish.
Hisano Y; Sakuma T; Nakade S; Ohga R; Ota S; Okamoto H; Yamamoto T; Kawahara A
Sci Rep; 2015 Mar; 5():8841. PubMed ID: 25740433
[TBL] [Abstract][Full Text] [Related]
17. Highly Efficient CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
Maguire JA; Cardenas-Diaz FL; Gadue P; French DL
Curr Protoc Stem Cell Biol; 2019 Feb; 48(1):e64. PubMed ID: 30358158
[TBL] [Abstract][Full Text] [Related]
18. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation.
Zhang H; Zhang J; Wei P; Zhang B; Gou F; Feng Z; Mao Y; Yang L; Zhang H; Xu N; Zhu JK
Plant Biotechnol J; 2014 Aug; 12(6):797-807. PubMed ID: 24854982
[TBL] [Abstract][Full Text] [Related]
19. Creating Knockin Alleles in Mouse Embryonic Stem Cells by CRISPR/Cas9-Mediated Homologous Recombination Without Drug Selection.
Liu P; Li Y; Lei J; Dong L
Methods Mol Biol; 2019; 1874():115-137. PubMed ID: 30353511
[TBL] [Abstract][Full Text] [Related]
20. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]